Electrochemical methods and devices for amending urine samples for immunosensor detection
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C12Q-001/58
G01N-033/543
G01N-033/68
G01N-033/62
출원번호
US-0472553
(2017-03-29)
등록번호
US-10234450
(2019-03-19)
발명자
/ 주소
Di Tullio, Katrina
Collier, G. Bruce
Campbell, John Lewis Emerson
출원인 / 주소
Abbott Point of Care Inc.
대리인 / 주소
Kilpatrick Townsend & Stockton LLP
인용정보
피인용 횟수 :
0인용 특허 :
18
초록▼
The present invention is directed to methods and devices for amending undiluted and partially diluted urine samples in a manner suitable for performing immunoassays for target analytes, for example NGAL. Generally, the urine sample is treated with reagents including at least one of buffer materials,
The present invention is directed to methods and devices for amending undiluted and partially diluted urine samples in a manner suitable for performing immunoassays for target analytes, for example NGAL. Generally, the urine sample is treated with reagents including at least one of buffer materials, water soluble proteins, urease, and other interferent mitigants. These reagents control the pH of the urine sample in a manner suitable for immuno-binding reactions and ameliorate interferences, particularly during the detection step.
대표청구항▼
1. A method for performing an immunoassay for a target analyte in an amended urine sample, the method comprising: providing a test device comprising: a first region comprising reagents; and a second region comprising a sensor comprising at least one electrode coated with a capture molecule capable o
1. A method for performing an immunoassay for a target analyte in an amended urine sample, the method comprising: providing a test device comprising: a first region comprising reagents; and a second region comprising a sensor comprising at least one electrode coated with a capture molecule capable of binding to the target analyte to form an immunocomplex, wherein the reagents comprise: (i) a water soluble protein for blocking non-specific binding of immunoglobulins at the at least one electrode, (ii) a buffer, and (iii) a scavenger for reducing non-specific current generation from electroactive species at the at least one electrode;contacting a urine sample with the reagents in the first region to amend the urine sample such that a dissolved concentration of the water soluble protein within the amended urine sample is in a range of about 0.02 to 225 mg/mL;contacting the amended urine sample with the second region to form the immunocomplex; anddetermining a concentration of the target analyte within the amended urine sample by detecting the immunocomplex using the at least one electrode. 2. The method of claim 1, wherein: the water soluble protein is recombinant or non-recombinant human serum albumin, porcine serum albumin, castor bean albumin, salmon serum albumin, bovine serum albumin, or a mixture thereof. 3. The method of claim 1, further comprising amending the urine sample with urease to reduce a urea concentration of the urine sample below a preselected urea threshold. 4. The method of claim 1, wherein the target analyte is neutrophil gelatinase-associated lipocalin (NGAL). 5. The method of claim 1, wherein: the buffer adjusts a pH of the urine sample to within a preselected range; andthe buffer is selected from the group consisting of: glycine, 3-(N-morpholino) propanesulfonic acid (MOPS), tris(hydroxymethyl)aminomethane (Tris), tricine, acetate, borate, 2-(N-morpholino)ethanesulfonic acid (MES), and 2-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]ethanesulfonic acid (TES). 6. The method of claim 1, further comprising amending the urine sample with glutamine synthetase or any other urea cycle enzyme to consume ammonium. 7. The method of claim 1, further comprising amending the urine sample with a sequestering enzyme to reduce and sequester excess phosphate below a preselected phosphate threshold. 8. The method of claim 7, wherein the sequestering enzyme is adenylate kinase. 9. A method for performing an immunoassay for a target analyte in an amended urine sample, the method comprising: introducing an undiluted or partially diluted urine sample into a sample chamber of a cartridge through a sample entry port;amending the urine sample with reagents such that a dissolved concentration of water soluble protein within the amended urine sample is in a range of about 0.02 to 225 mg/mL, wherein the reagents comprise: (i) a water soluble protein for blocking non-specific binding of immunoglobulins at a sensor, (ii) a buffer, (iii) a conjugate molecule labeled with an enzyme capable of binding to the target analyte, and (iv) a scavenger for reducing non-specific current generation from electroactive species at at least electrode;contacting the amended urine sample with a sensor on the cartridge, wherein the sensor comprises a capture molecule and the at least one electrode, the a capture molecule is capable of binding to the target analyte bound to the conjugate molecule labeled with the enzyme to form an immunocomplex, and the at least one electrode is configured to detect the immunocomplex; anddetermining a concentration of the target analyte within the amended urine sample by detecting the immunocomplex using the at least one electrode. 10. The method of claim 9, wherein: the water soluble protein is recombinant or non-recombinant human serum albumin, porcine serum albumin, castor bean albumin, salmon serum albumin, bovine serum albumin, or a mixture thereof. 11. The method of claim 9, further comprising amending the urine sample with urease to reduce a urea concentration of the urine sample below a preselected urea threshold. 12. The method of claim 9, wherein the target analyte is neutrophil gelatinase-associated lipocalin (NGAL). 13. The method of claim 9, wherein: the buffer adjusts a pH of the urine sample to within a preselected range; andthe buffer is selected from the group consisting of: glycine, 3-(N-morpholino) propanesulfonic acid (MOPS), tris(hydroxymethyl)aminomethane (Tris), tricine, acetate, borate, 2-(N-morpholino)ethanesulfonic acid (MES), and 2-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]ethanesulfonic acid (TES). 14. The method of claim 9, further comprising amending the urine sample with glutamine synthetase or any other urea cycle enzyme to consume ammonium. 15. The method of claim 9, further comprising amending the urine sample with a sequestering enzyme to reduce and sequester excess phosphate below a preselected phosphate threshold. 16. The method of claim 15, wherein the sequestering enzyme is adenylate kinase.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (18)
Davis,Graham; Lauks,Imants R.; Lin,Chao; Miller,Cary James, Apparatus and methods for analyte measurement and immunoassay.
Lauks Imants R. (Yardley PA) Wieck Henry J. (Brooklyn NY) Zelin Michael P. (Plainsboro NJ) Blyskal Philip (Plainsboro NJ), Disposable sensing device for real time fluid analysis.
Khalil Omar S. (Libertyville IL) Hanna Charles F. (Libertyville IL) Zurek Thomas F. (River Forest IL) Grigalauski Denise A. (Wildwood IL), Immunoassay device with liquid transfer between wells by washing.
Khalil Omar S. (Libertyville IL) Zurek Thomas F. (River Forest IL) Genger Kevin R. (Chicago IL) Pepe Curtis J. (McHenry IL) Jou Yi-Her (Vernon Hills IL) Cotter Stephen M. (Fox Lake IL), Method and apparatus for heterogeneous chemiluminescence assay.
Cozzette Stephen N. (Hightstown NJ) Davis Graham (Plainsboro NJ) Itak Jeanne (Hamilton NJ) Lauks Imants R. (Yardley PA) Mier Randall M. (Ottawa NJ CAX) Piznik Sylvia (Jackson NJ) Smit Nicolaas (Hight, Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor.
Davis Graham (Princeton NJ) Lauks Imants R. (Rockcliffe Park CAX) Pierce Raymond J. (Ottawa PA CAX) Widrig Cindra A. (North Wales PA), Method of measuring gas concentrations and microfabricated sensing device for practicing same.
Cozzette Stephen N. (Nepean CAX) Davis Graham (Plainsboro NJ) Lauks Imants R. (Yardley PA) Mier Randall M. (Morrisvile PA) Piznik Sylvia (Jackson NJ) Smit Nicolaas (Hightstown NJ) Van Der Werf Paul (, Process for the manufacture of wholly microfabricated biosensors.
Cozzette Stephen N. (Nepean CAX) Davis Graham (Plainsboro NJ) Itak Jeanne A. (North Brunswick NJ) Lauks Imants R. (Yardley PA) Mier Randall M. (Morrisville PA) Piznik Sylvia (Jackson NJ) Smit Nicolaa, Wholly microfabricated biosensors and process for the manufacture and use thereof.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.